Migraine Trial, Recruiting NCT06959004 Sponsor: Danish Headache Center Condition: Migraine
Back to Migraine

Migraine Trial, Recruiting

NCT06959004
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 to 65 years old at the time of screening
  • People who weigh between 50 and 100 kg
  • People who have had a history of migraine without aura for at least 12 months, diagnosed according to established international headache criteria
  • People who have had an average of 1 to 5 migraine days without aura per month over the 3 months before screening

Who may not be able to join:

  • People with any history of a headache disorder other than migraine without aura or infrequent tension-type headaches
  • People with any history of moderate or severe traumatic brain injury
  • People with any history of heart or blood vessel disease, including stroke-related conditions
  • People with any history of lung disease
  • People with any other significant medical condition, disorder, or disease that the trial doctor believes could affect safety or interfere with the study
  • People with a history of suicidal behaviour or who are considered at risk of harming themselves or others
  • Women who are able to become pregnant and have a positive pregnancy test at any point during the study
  • People with high blood pressure (systolic at or above 150 mmHg and/or diastolic at or above 100 mmHg) before the infusion on the treatment day
  • People with low blood pressure (systolic at or below 90 mmHg and/or diastolic at or below 50 mmHg)
  • People who take any medication daily, other than contraceptives
  • People who have taken any medication other than contraceptives within 48 hours before the infusion
  • People who have had a headache of any level of intensity within 48 hours before the infusion
  • People who have had a migraine attack within 5 days before the infusion
  • People who have experienced a migraine aura within 48 hours before the infusion

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +4541598494

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Danish Headache Center
Registry
ClinicalTrials.gov
Start date
13 May 2025
Est. completion
1 May 2026

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

Incidence of migraine attacks without aura

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov